Barclays’s Insight Molecular Diagnostics Inc. Common Stock IMDX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-2
| Closed | – | – | 4776 |
|
2022
Q2 | $0 | Sell |
2
-486
| -100% | – | ﹤0.01% | 4855 |
|
2022
Q1 | $14K | Sell |
488
-3,164
| -87% | -$90.8K | ﹤0.01% | 4415 |
|
2021
Q4 | $158K | Buy |
3,652
+2,422
| +197% | +$105K | ﹤0.01% | 2883 |
|
2021
Q3 | $87K | Buy |
1,230
+721
| +142% | +$51K | ﹤0.01% | 3268 |
|
2021
Q2 | $58K | Sell |
509
-4,974
| -91% | -$567K | ﹤0.01% | 3337 |
|
2021
Q1 | $569K | Buy |
5,483
+1,964
| +56% | +$204K | ﹤0.01% | 2588 |
|
2020
Q4 | $168K | Sell |
3,519
-418
| -11% | -$20K | ﹤0.01% | 2772 |
|
2020
Q3 | $110K | Sell |
3,937
-2,255
| -36% | -$63K | ﹤0.01% | 2999 |
|
2020
Q2 | $237K | Sell |
6,192
-2,681
| -30% | -$103K | ﹤0.01% | 2722 |
|
2020
Q1 | $434K | Buy |
8,873
+336
| +4% | +$16.4K | ﹤0.01% | 2187 |
|
2019
Q4 | $384K | Buy |
8,537
+8,007
| +1,511% | +$360K | ﹤0.01% | 2836 |
|
2019
Q3 | $22K | Sell |
530
-163
| -24% | -$6.77K | ﹤0.01% | 3833 |
|
2019
Q2 | $35K | Sell |
693
-216
| -24% | -$10.9K | ﹤0.01% | 3896 |
|
2019
Q1 | $72K | Buy |
+909
| New | +$72K | ﹤0.01% | 3489 |
|
2018
Q4 | – | Hold |
0
| – | – | – | 4289 |
|
2018
Q3 | – | Hold |
0
| – | – | – | 4416 |
|
2018
Q2 | – | Sell |
-40
| Closed | -$2K | – | 4315 |
|
2018
Q1 | $2K | Buy |
40
+9
| +29% | +$450 | ﹤0.01% | 4091 |
|
2017
Q4 | $3K | Buy |
31
+26
| +520% | +$2.52K | ﹤0.01% | 3934 |
|
2017
Q3 | $1K | Buy |
+5
| New | +$1K | ﹤0.01% | 3940 |
|
2017
Q2 | – | Sell |
-53
| Closed | -$6K | – | 4010 |
|
2017
Q1 | $6K | Buy |
+53
| New | +$6K | ﹤0.01% | 3617 |
|
2016
Q4 | – | Hold |
0
| – | – | – | 3939 |
|
2016
Q3 | – | Sell |
-15
| Closed | -$1K | – | 4021 |
|
2016
Q2 | $1K | Buy |
+15
| New | +$1K | ﹤0.01% | 3438 |
|
2016
Q1 | – | Sell |
-10
| Closed | -$1K | – | 3607 |
|
2015
Q4 | $1K | Buy |
+10
| New | +$1K | ﹤0.01% | 3102 |
|